4 things to know about NuVasive’s AttraX Putty

NuVasive’s biologics portfolio includes AttraX Putty.

Advertisement

Here are four things to know.

1. AttraX Putty is a synthetic, resorbable, osteoconductive bone void filler intended for the repair of bony defects.

2. AttraX Putty’s calcium phosphate granules have a biotextured surface structure to facilitate 3D bone regeneration in the defect site into which the putty is implanted.

3. The AttraX implant is replaced by bone during natural bone remodeling.

4. The technology received FDA clearance in October 2015 and has been used globally since 2011.

More articles on biologics:

Target stem cells to stop osteoarthritis progression, study suggests: 3 insights

Stem cell-derived neurons survive grafting into spinal cord injury in animal study: 3 things to know

FDA seeks to shut down stem cell clinics offering unapproved treatments: 5 insights

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Biologics

Advertisement

Comments are closed.